Michael Smith Laboratories • Posted: January 25, 2021
Dr. Stephen Withers is named one of nine recipients of the 2020 Innovation to Commercialization Program Award from the Michael Smith Foundation of Health Research
Congratulations to GlycoNet Investigator Dr. Stephen Withers, Professor at the University of British Columbia, for being named one of nine recipients across British Columbia to receive a 2020 Innovation to Commercialization (I2C) Program Award. This award is granted from the Michael Smith Foundation for Health Research (MSFHR) to support researchers to advance their discoveries or inventions towards practical application, resulting in products or technologies that improve health outcomes and enrich BC’s health innovation ecosystem.
Withers’ funding award will assist in his research focusing on using new technologies in glycomics that act on A and B blood types to generate ‘Universal Donor’ O type blood, which is often found in short supply.
Read the full announcement from the Michael Smith Laboratories.
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.